BARROW ROBERT (Chief Executive Officer) sold 3.2% of their position (25.79K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $339.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/29/2025ACC: 0001193125-25-335483
DirectorOfficer· Chief Executive Officer
Since Jan 2022
-25.79K
Net shares
Net seller
$339.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
25.79K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−25.79K
Price / share
$13.15
Trade value
$339.07K
% of position
3.2%
12/26/2025
804.27K→778.48K
Total
Net shares
−25.79K
Net value
-$339.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 12/26/2025 | S · Sale | −25.79K | $13.15 | $339.07K | 3.2% | 804.27K | 778.48K |
| Total | −25.79K | -$339.07K | ||||||
Derivative Transactions0
No derivative transactions reported